NORTH PHILADELPHIA (WPVI) -- Pacemakers and defibrillators have saved an untold number of Americans with heart problems. Still, some who could benefit from them are reluctant to get them. In this week ...

Less than a month after Charles “Chick” Woodfall, 78, got his defibrillator implanted in 2000, he and his wife, Nancy, 72, traveled in their nearly 27-foot motor home from the Palo Alto area to Morro ...

It was curiosity that led Dr. Joshua Greenberg, a heart rhythm fellow at Henry Ford Hospital in Detroit, to suggest testing his iPhone 12 Pro to see whether the strong magnets inside might affect an ...

Magnets and other components inside iPhone 12 devices could disable pacemakers or implanted cardiac defibrillators, tech giant Apple has warned, potentially putting millions of people at risk for ...

Sometimes a slow heart rhythm can cause people to experience tiredness, difficulty with exercise, or dizziness and fainting. Although other problems can cause these symptoms (for example, blood loss ...

Medtronic has issued a warning about rapid unexpected battery depletion that may happen in seven kinds of implantable defibrillators, affecting nearly 340,000 implanted devices worldwide. The Food and ...

You probably know enough to back up a few feet when using the microwave if you have a cardiac rhythm device such as a pacemaker implanted in your chest. Holding your iPad too close could also cause ...

WASHINGTON — Malfunctions in implanted heart defibrillators were on the rise even before this summer’s massive recall by Guidant, government and Harvard University scientists reported yesterday. About ...

EnRhythm(TM) pacemaker and EnTrust(TM) defibrillators now available in Europe Medtronic, Inc. (NYSE:MDT) today announced the European introductions of the Medtronic EnRhythm(TM) pacemaker ...

Malfunctions in implanted heart defibrillators were on the rise even before this summer’s massive recall by Guidant Corp., government and Harvard University scientists reported Friday. More than half ...

BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S.